Eva González‐Barca

Also affiliated with Institut d'Investigació Biomédica de Bellvitge, Ajuntament de L’Hospitalet, Institut Català d'Oncologia, Duran i Reynals Hospital, National Cheng Kung University Hospital, Universitat de Barcelona

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial”.

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02321

N/A

1.9DataRank · unranked

62 citations

Fátima De la Cruz, Ana Jiménez Ubieto, Javier López‐Jiménez, Alejandro Martı́n, María José Terol +18 more

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

Microbiology Spectrum(2022)10.1128/spectrum.02292-21

N/A

0DataRank · unranked

32 citations

Adaia Albasanz‐Puig, Ana Fernández‐Cruz, Marina Machado, Andrés Novo, David van Duin +29 more

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

UNC Libraries(2024)10.17615/k3w3-3x33

N/A

0DataRank · unranked

0 citations

Álvarez-Uría A., del Pozo J.L., Natàlia Pallarés, Jordi Carratalà, Nadia Castaldo +30 more